•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.SEC and Express Settle Charges Related to Disclosure Obligations
Is It Too Late to Buy American Express Stock?
International Money Express: This Global Remittance Play Is Now An Activist Target
American Express Declares Regular Quarterly Dividend
BlueBean Joins American Express Sync™
American Express stock has upside, but a pullback can't be ruled out
American Express Plans Live Audio Webcast of Third Quarter 2024 Earnings Conference Call
Voss Capital wants to maximize shareholder value at International Money Express. How it may play out
Tradepulse Power Inflow Alert: American Express Inc. Moves Up Over 4% After Alert For The Day
Should You Buy American Express While It's Below $300?
Where Will American Express Stock Be in 3 Years?
Why American Express Is Trading Higher Today
Berkshire Hathaway Holds Bank of America, American Express, Visa, and Mastercard Stock, but So Does This Low-Cost Vanguard ETF
American Express, Knot Enhance Card Members' Checkout Experience
Stitch Fix Adds Timothy Baxter and Fiona Tan to its Board of Directors
American Express: Consumer Confidence Rebound Is Big
American Express: Overtaking Visa
UNIPaaS and American Express Partner to Boost B2B Card Payments for SaaS Platforms
International Money Express, Inc. Secures $425 Million Credit Facility
Celltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab on their medical benefit formulary
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.